22 October 2015 - PHARMAC is seeking feedback on a provisional agreement with Baxter Healthcare Limited to list Asacol (mesalazine) 800 mg tablets (90 tablet pack) in the New Zealand Pharmaceutical Schedule from 1 January 2016.

For more details, go to: http://www.pharmac.health.nz/news/new-news-page-8/